Life Science Company News

Results 281 - 300 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »

NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Pieper Veterinary Partners with Lebanon Veterinary Hospital in Lebanon CT

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Benchmark Recognized by U.S. News & World Report with 62 "Best" Senior Living Community Excellence Awards

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Alport Syndrome Market to Witness Upsurge in Growth at a Massive CAGR of 69% by 2034 | DelveInsight

Read more ››
By: PR Newswire Association LLC. - 17 Apr 2024

Tilray Brands Lights Up 420 With Music Festivals and Celebrations Across The Country

Read more ››
By: GlobeNewswire - 17 Apr 2024

First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase

Read more ››
By: GlobeNewswire - 17 Apr 2024

Treace to Present at Bank of America Health Care Conference

Read more ››
By: GlobeNewswire - 17 Apr 2024

atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology

Read more ››
By: GlobeNewswire - 17 Apr 2024

Elara Caring Partners with Constant Therapy to Deliver First AI-Driven Speech-Language and Cognitive Therapy at Scale

Read more ››
By: GlobeNewswire - 17 Apr 2024

Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 17 Apr 2024

Repligen to Report First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 17 Apr 2024

Ocean Drive Plastic Surgery Founder Dr. Alan Durkin Appointed VIO Med Spa Chief Medical Officer

Read more ››
By: GlobeNewswire - 17 Apr 2024

Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders

Read more ››
By: GlobeNewswire - 17 Apr 2024

Zylö announces the creation and spinout of Atticus Pharma Inc.

Read more ››
By: GlobeNewswire - 17 Apr 2024

BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates

Read more ››
By: GlobeNewswire - 17 Apr 2024

Psyence Biomed Announces Phase IIb Clinical Trial Listing on the Australian New Zealand Clinical Trials Registry (ANZCTR)

Read more ››
By: GlobeNewswire - 17 Apr 2024

Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor

Read more ››
By: GlobeNewswire - 17 Apr 2024

New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes

Read more ››
By: GlobeNewswire - 17 Apr 2024

Recce Pharmaceuticals Completes 5,000 RECCE® 327 Doses a Week under Good Manufacturing Practice (GMP)

Read more ››
By: GlobeNewswire - 17 Apr 2024

Immutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer

Read more ››
By: GlobeNewswire - 17 Apr 2024
Results 281 - 300 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate